Self-management Compared to Care-as-usual for Men With Lower Urinary Tract Symptoms
URincontrol4men: Self-management Through an App, Compared to the Consultation of a General Practitioner for Men With Lower Urinary Tract Symptoms
1 other identifier
interventional
175
1 country
1
Brief Summary
Research question: Does offering an online self-management program lead to more efficient use of care by men with urinary complaints? Hypothesis: Many men with urinary symptoms receive medication from their GP. Advice on how to self-manage complaints is often skipped. This while self-management is effective. By offering self-management instead of visiting a GP the use of care by men with urinary complaints may decrease and treatment may become more efficient. Study design: Men are randomized to receive either care-as-usual by their GP or the online self-management program. Men will be followed for six months and the cost-effectiveness of the online self-management intervention will be compared to the care-as-usual
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2022
CompletedStudy Start
First participant enrolled
April 8, 2022
CompletedFirst Posted
Study publicly available on registry
May 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2024
CompletedDecember 13, 2024
December 1, 2024
2.7 years
April 1, 2022
December 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Patient Global Impression of Improvement (PGI-I)
The PGII is a single-question global index for change of incontinence symptoms that is rated with a 7-point Likert scale ranging from "very much worse" to "very much better." This variable will be dichotomized into "improved" (scores ≥ "better") and "not improved."
6 months
Secondary Outcomes (5)
International Consultation on Incontinence Questionnaire Male Lower Urinary Tract Symptoms Module (ICIQ-MLUTS)
6 weeks and 6 months
International Prostate Symptom Score Quality of Life (IPSS QoL)
6 weeks and 6 months
the EuroQol instrument (EQ-5D-5L)
6 weeks and 6 months
iMTA Medical Consumption Questionnaire (iMCQ)
6 months
iMTA Productivity Cost Questionnaire (iPCQ)
6 months
Study Arms (2)
Care as usual
ACTIVE COMPARATORCAU will be that typically provided by GPs. Also patients will be informed about a page on thuisarts.nl regarding male LUTS. The pragmatic trial design means that care can vary depending on the preferences of patients and GPs in this group.
Online self-management intervention
EXPERIMENTALParticipants in the intervention group will be given access to an online self-management program that will be personalized. This program was developed based on the results of a literature search, the opinions of expert Dutch GPs and urologists, and a pilot study in secondary care, with further preliminary testing in primary care. The program consists of nine components: information, pelvic floor exercises, bladder training, sitting voiding position, urethral milking, fluid management, caffeine avoidance, alcohol avoidance, and physical activity increase. Information is presented as text with supportive figures, plus audio (a "read aloud function" for all text) and video fragments to facilitate engagement by men with low literacy levels.
Interventions
CAU will be that typically provided by GPs. Also patients will be informed about a page on thuisarts.nl regarding male LUTS. The pragmatic trial design means that care can vary depending on the preferences of patients and GPs in this group.
Eligibility Criteria
You may qualify if:
- Men with lower urinary tract symptoms who are thinking about visiting a GP for their complaints
You may not qualify if:
- Men with complicated LUTS who should seek urgent care, including those with nocturnal incontinence (e.g., chronic urinary retention), the inability to void despite urgency (e.g., acute urinary retention), and with sudden onset or worsening LUTS (e.g., urinary tract infections).
- Men receiving treatment from a pelvic physiotherapist, GP, or urologist (including at any point in the previous year).
- Men with a history of prostate cancer, bladder cancer, or urinary tract surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Medical Center Groningenlead
- ZonMw: The Netherlands Organisation for Health Research and Developmentcollaborator
- Bekkenbodem4Allcollaborator
- Leiden University Medical Centercollaborator
- University of Twentecollaborator
- Isalacollaborator
Study Sites (1)
University Medical Center Groningen
Groningen, 9713GZ, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marco Blanker
University Medical Center Groningen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2022
First Posted
May 2, 2022
Study Start
April 8, 2022
Primary Completion
December 5, 2024
Study Completion
December 5, 2024
Last Updated
December 13, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- After publishing of the manuscripts related to this study
- Access Criteria
- Requests for re-use of data will be evaluated by the Principal Investigator who will check whether the research question falls within the scope of the informed consent. There will be terms and conditions drawn up in a contract for re-using data by third parties.
The processed, anonymised data will be made available in DataverseNL and a persistent identifier to a minimal dataset(s) will be given in the publication(s).